The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
In this article, we will explore the latest innovations in the dental space and delve into the importance of autoclaves in maintaining a safe and sterile environment.
Results of the study on devices coated with paclitaxel were presented today at the TCT 2023 meeting in San Francisco, the world’s largest interventional cardiology meeting. The study shows no increased risk of death from use of paclitaxel-coated devices and has simultaneously been published on a fast-track basis by The Lancet.
The decision to form PeekMed LLC is driven by a desire to strengthen presence in the world’s largest and most influential healthcare market. This expansion will enable PeekMed to offer versatile solutions and provide timely support to its growing customer base in the US.
“Momentum MIS is truly among the leading next generation MIS solutions on the market in terms of performance and adaptability”, said Jim Bruty, Chief Operating Officer at ulrich medical USA.Visit the ulrich medical booth (#1635) in Los Angeles to learn more.
“The MDR certification gives Neoss the freedom to continue innovating intelligent solutions that benefit our customer and their patients. The MDR certification also shows that Neoss products are backed with clinical evidence of the highest standard and ensures that the products are continuously monitored in post-market studies.” Mr. Fredrik Engman, CTO and co-founder of Neoss.”
The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.